Background Based on previous findings, we hypothesised that radiotherapy to the prostate
would improve overall survival in men with metastatic prostate cancer, and that the benefit …

PlasmoDB ( http://PlasmoDB.org ) is the official database of the Plasmodium falciparum
genome sequencing consortium. This resource incorporates the recently completed P. …

ToxoDB ( http://ToxoDB.org ) is a genome and functional genomic database for the protozoan
parasite Toxoplasma gondii . It incorporates the sequence and annotation of the T. gondii …

Background Metastatic castration-resistant prostate cancers are enriched for DNA repair
gene defects (DRDs) that can be susceptible to synthetic lethality through inhibition of PARP …

Background The optimal timing of radiotherapy after radical prostatectomy for prostate cancer
is uncertain. We aimed to compare the efficacy and safety of adjuvant radiotherapy versus …

Purpose Up to 30% of patients who undergo radiation for intermediate- or high-risk localized
prostate cancer relapse biochemically within 5 years. We assessed if biochemical disease-…

Background Men with high-risk non-metastatic prostate cancer are treated with androgen-deprivation
therapy (ADT) for 3 years, often combined with radiotherapy. We analysed new …

Background and purpose FAST-Forward is a phase 3 clinical trial testing a 1-week course
of whole breast radiotherapy against the UK standard 3-week regimen after primary surgery …

Purpose We evaluated angiogenesis-targeted sunitinib therapy in a randomized, double-blind
trial of metastatic castration-resistant prostate cancer (mCRPC). Patients and Methods …

Objective COVID-19 can rarely lead to severe illness in pediatric patients. The aim of this
study was to determine if severe outcomes in pediatric COVID-19 have changed over the …